LIMINATUS PHARM - 53 Year Dividend History | LIMN

Historical dividend payout and yield for LIMINATUS PHARM (LIMN) since 1972. The current TTM dividend payout for LIMINATUS PHARM (LIMN) as of May 08, 2025 is $0.00. The current dividend yield for LIMINATUS PHARM as of May 08, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.000B $0.000B
Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.886B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Aduro Clean Technologies (ADUR) Canada $0.157B 0.00
Range Capital Acquisition (RANG) United States $0.144B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.099B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.092B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Youxin Technology (YAAS) China $0.040B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.035B 0.00
Sky Quarry (SKYQ) United States $0.015B 0.00
PicoCELA (PCLA) Japan $0.011B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.010B 0.00
SMART DGTL GRP (SDM) $0.000B 0.00
WINCHESTER BCP (WSBK) $0.000B 0.00
YUANBAO INC (YB) China $0.000B 0.00
CANTOR EQ PT II (CEPT) $0.000B 0.00